首页> 美国卫生研究院文献>Human Vaccines Immunotherapeutics >Parental risk factors for fever in their children 7–10 days after the first dose of measles-containing vaccines
【2h】

Parental risk factors for fever in their children 7–10 days after the first dose of measles-containing vaccines

机译:初次接种含麻疹疫苗后7-10天父母患儿发烧的危险因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

We evaluated whether parental clinical conditions were associated with fever after a first dose of measles-containing vaccine (MCV) in the child in a cohort study including 244,125 children born in Kaiser Permanente Northern California between 2009 and 2016 who received MCV between ages 1 and 2 years. Each child was linked with his/her mother and father when possible. Parental clinical conditions present before and after their child’s birth were identified. We defined fever in the children as clinic and emergency department visits with a fever code 7–10 days after a first dose of MCV (“MCV-associated fever”). We evaluated parental clinical conditions associated with MCV-associated fever using multivariate logistic regression analyses. After adjusting for multiple factors, including healthcare utilization, maternal fever [odds ratio (OR) = 1.19, 95% confidence interval (CI) 1.06–1.32], fever after MCV (OR = 5.90, 95% CI 1.35–25.78), respiratory infections (OR = 1.20, 95% CI 1.10–1.31), migraine (OR = 1.14, 95% CI 1.05–1.24), syncope (OR 1.14, 95% CI 1.01–1.27), and essential thrombocythemia (OR = 1.93, 95% CI 1.15–3.25) were significantly associated with MCV-associated fever. Paternal respiratory infections (OR = 1.15, 95% CI 1.05–1.27), fever associated with respiratory infections (OR = 1.47, 95% CI 1.23–1.76), and vitiligo (OR = 1.63, 95% CI 1.06–2.53) were significantly associated with MCV-associated fever. Parental clinical conditions, specifically fever alone and fever associated with respiratory infection, are associated with fever in their child 7–10 days after MCV.
机译:在一项队列研究中,我们评估了该儿童的首剂含麻疹疫苗(MCV)后父母的临床状况是否与发烧相关,该研究包括2009年至2016年间在北加州凯撒永久居民出生的244,125名儿童,年龄在1-2岁之间年份。如有可能,每个孩子都与他/她的母亲和父亲联系在一起。确定了孩子出生前后父母的临床状况。我们将儿童发烧定义为在初次服用MCV(“ MCV相关发烧”)后7-10天发烧的门诊和急诊科。我们使用多元逻辑回归分析评估了与MCV相关发烧相关的父母临床状况。在对包括医疗保健利用率在内的多种因素进行调整后,产妇发烧[几率(OR)= 1.19,95%置信区间(CI)1.06-1.32],MCV后发烧(OR = 5.90,95%CI 1.35–25.78),呼吸感染(OR = 1.20,95%CI 1.10–1.31),偏头痛(OR = 1.14,95%CI 1.05–1.24),晕厥(OR 1.14,95%CI 1.01–1.27)和原发性血小板增多症(OR = 1.93,95 %CI 1.15–3.25)与MCV相关的发烧显着相关。父亲呼吸道感染(OR = 1.15,95%CI 1.05–1.27),伴有呼吸道感染的发烧(OR = 1.47,95%CI 1.23–1.76)和白癜风(OR = 1.63,95%CI 1.06–2.53)显着与MCV相关的发烧有关。父母的临床状况,特别是单纯发烧和与呼吸道感染相关的发烧,与他们的孩子在MCV感染后7-10天发烧有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号